| 标题 |
The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel in Patients with Multiple Myeloma and 1-3 Prior Lines of Therapy (Cohort A) and with Early Relapse after First Line Treatment (Cohort B) |
| 网址 | |
| DOI |
10.1182/blood-2023-178882
doi
|
| 其它 |
期刊:Blood 作者:J. Hillengass; Adam D. Cohen; M. Agha; M. Delforge; T. Kerre; et al 出版日期:2023-11-28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)